causal
Analysis v1
Even if you don’t have diabetes, if you’re overweight and have heart disease, a weekly shot of semaglutide can cut your risk of heart attack or stroke by 1 in 5 — and this benefit starts before you lose much weight.
Evidence from Studies
Supporting (0)
0
Community contributions welcome
No supporting evidence found
Contradicting (1)
0
Community contributions welcome
1
Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs
Narrative Review
Human
2024 Aug 9This study talks generally about a group of weight-loss and diabetes drugs that might help the heart, but it doesn’t prove that one specific drug (semaglutide 2.4 mg) cuts heart risks by 20% in obese people with heart disease, independent of weight loss.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.